Connect with us

Transfer News

Rasmus Højlund to Man United! -Man UTD finalizing 72m deal with medicals set and announcement soon as superstar keen to join the squad for preseason

Published

on

Rasmus Højlund to Man United! -Man UTD finalizing 72m deal with medicals set and announcement soon as superstar keen to join the squad for preseason

Manchester United have reached an agreement with Serie A side Atalanta over the signing of striker Rasmus Hojlund; United hopeful 20-year-old can feature in pre-season pending medical and confirmation of personal terms

Manchester United have agreed a deal to sign Atalanta’s Rasmus Hojlund
Manchester United are finalising a £72m deal to sign striker Rasmus Hojlund from Atalanta.

United hope to have Hojlund’s medical completed this week and for a five-year deal – with the option of a further year – to be formalised in time for him to play some part in one of the team’s remaining pre-season fixtures.

United have two games this weekend, against Lens on Saturday and Athletic Bilbao on Sunday.

The deal for Hojlund is worth an initial £64m, plus £8m in performance-related add-ons. Atalanta went into negotiations wanting £77m guaranteed.

As previously reported by Sky Sports News, the forward’s destination of choice has been Old Trafford, so there was no concern over PSG’s interest in the Denmark international.

Personal terms were no issue, with Hojlund agreeing a five-year contract with the option of an additional 12 months.

The Premier League side were handed a boost on Saturday when Atalanta signed Almeria forward El Bilal Toure, while Hojlund was left out of the squad that played Bournemouth in a pre-season friendly.

United’s incoming business is now largely done, and any more arrivals are likely to depend on departures.

There is interest in the likes of Harry Maguire, Scott McTominay, Fred and Donny van de Beek.

If there are exits, United are understood to be ready to go into the market to replace them.

Strong interest remains in Fiorentina midfielder Sofyan Amrabat.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *